Single Center Registry of Non-STEMI Acute Coronary Syndrome Patients Treated With Bivalirudin
Completed
- Conditions
- Non-STEMI Acute Coronary Syndrome
- Registration Number
- NCT00842374
- Lead Sponsor
- Minneapolis Heart Institute Foundation
- Brief Summary
This is a registry of patients with non ST segment elevation Myocardial Infarction (heart attack) and/or unstable acute coronary artery syndrome treated with a standardized protocol including Bivalirudin.
Data will be collected on diagnosis, treatment and outcomes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
-
Age ≥ 18
-
Chest pain or symptoms believed to be an anginal equivalent and representing myocardial ischemia, lasting at least 10 minutes within the past 24 hours
-
Having any one of the following:
- Ischemic changes on ECG: ST depression >0.5 mm OR T wave inversion >2 mm
- Positive cardiac markers
- New onset CHF presumed secondary to ischemia
- Pulmonary edema
- Known coronary artery disease with typical symptoms
- Hemodynamic instability
- Sustained ventricular tachycardia
Exclusion Criteria
- For the purpose of the SSDI, patients will be excluded if we are unable to obtain their Social Security Number.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of MACE defined as any one of the following: • Acute myocardial infarction/reinfarction • Ischemia-driven unplanned revascularizations • Stroke • All cause Mortality 30 days
- Secondary Outcome Measures
Name Time Method Rehospitalization for ACS 30 days Major Bleeding in hospital and at 30 days All cause mortality 30 days, one year and up to 5 years
Trial Locations
- Locations (1)
Ridgeview Medical Center
🇺🇸Waconia, Minnesota, United States